Skip to main content
Premium Trial:

Request an Annual Quote

Perlegen to Identify Heart Attack Gene Variants for AstraZeneca

NEW YORK, Jan. 9  (GenomeWeb News) - Perlegen Sciences and AstraZeneca will collaborate in a study that aims to find gene variants that increase the risk for heart attack, Perlegen said today.

 

Perlegen, of Mountain View, Calif., plans to genotype for AstraZeneca over one thousand samples to identify SNPs in genes and other genetic loci that are associated with heart attack.

 

The agreement follows on the heels of two research collaborations with Pfizer, in the areas of Major Depression Disorder and Metabolic Syndrome, that Perlegen announced earlier this week.

 

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.